EP2111462A2 - Milieu de détection et/ou d'identification de bactéries - Google Patents

Milieu de détection et/ou d'identification de bactéries

Info

Publication number
EP2111462A2
EP2111462A2 EP08762042A EP08762042A EP2111462A2 EP 2111462 A2 EP2111462 A2 EP 2111462A2 EP 08762042 A EP08762042 A EP 08762042A EP 08762042 A EP08762042 A EP 08762042A EP 2111462 A2 EP2111462 A2 EP 2111462A2
Authority
EP
European Patent Office
Prior art keywords
beta
enzyme
coli
galactosidase
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08762042A
Other languages
German (de)
English (en)
French (fr)
Inventor
Daniel Monget
Sylvain Orenga
John Perry
Michel Peyret
Céline ROGER-DALBERT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Publication of EP2111462A2 publication Critical patent/EP2111462A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/10—Enterobacteria

Definitions

  • the field of the invention is that of microbiological biochemical analysis, and in particular the detection and identification of bacteria.
  • Pathogenic bacteria including gram-negative bacilli, such as Enterobacteriaceae, are responsible for many diseases, epidemics, etc.
  • the species E. coli ⁇ Escherichia coli) is the most represented aerobic species in the digestive tract. . However, their presence in water is a witness of faecal contamination, and some strains are pathogenic and responsible for peritoneal, biliary, appendicular or genital suppuration.
  • E. coli Early and specific detection of E. coli makes it possible to propose a suitable solution, in terms of treatment, of decontamination ...
  • This detection can be based notably on the use of detection media comprising particular substrates, specific for a metabolic activity, called target metabolic activity, such as that an enzymatic activity of the bacterium that one wishes to detect: by the choice of substrates, depending on whether there is reaction or not, it is possible to characterize the nature of a microorganism.
  • the CPS ID 3 medium bioMerieux
  • the invention proposes to solve the problems of the state of the art by presenting a new medium particularly suitable for identifying E. coli bacteria in a fast, inexpensive and easy to implement manner.
  • an adapted complementary test allows a fast and easy detection of E. coli. More specifically, the inventors in particular, that an indole test carried out on E. coli which does not express the target metabolic activity makes it possible to increase the sensitivity of the test.
  • Biological sample means a clinical sample, taken from a sample of biological fluid, or a food sample, derived from any type of food or an environmental sample such as a surface sample, water sample,
  • This sample may thus be liquid or solid and may be mentioned in a nonlimiting manner, a clinical sample of blood, plasma, urine, faeces, nose samples, throats, skin, wounds, cerebrospinal fluid, a food sample of water, drinks such as milk, fruit juice; yogurt, meat, eggs, vegetables, mayonnaise, cheese; fish ..., a food sample from a feed intended for animals, such as in particular a sample from animal meal.
  • detection medium is meant a medium comprising all the elements necessary for the survival and / or growth of microorganisms.
  • This detection medium can either serve only as a detection medium, or a culture and detection medium.
  • the culture of the microorganisms is carried out before seeding, and in the second case, the detection medium also constitutes the culture medium.
  • the culture medium according to the invention may contain any other additives, for example: peptones or tissue extracts, one or more growth factors, carbohydrates, one or more selective agents, buffers, one or more gelling agents ...
  • This culture medium can be in the form of a liquid, a ready-to-use gel, that is to say ready for seeding in a tube, a bottle, or on a petri dish.
  • the detection may be carried out in a liquid medium, strip or other solid support
  • substrate any molecule capable of generating directly or indirectly a detectable signal due to an enzymatic or metabolic activity of the microorganism.
  • the substrate may in particular be a metabolic substrate, such as a source of carbon or nitrogen, coupled to an indicator producing a coloration in the presence of one of the products of the metabolism.
  • the substrate can also be an enzymatic substrate, that is to say a substrate that can be hydrolyzed by an enzyme into a product allowing the direct or indirect detection of a microorganism.
  • This substrate may in particular comprise a first specific part of the enzymatic activity to be revealed and a second part serving as a marker, hereinafter referred to as a marker part.
  • This marker part can be chromogenic, fluorogenic, luminescent, etc.
  • chromogenic substrate well suited to solid supports (filter, agar, electrophoresis gel), mention may be made in particular of substrates based on indoxyl and its derivatives, and substrates based on hydroxyquinoline or esculetin and their derivatives, which allow the detection of osidase and esterase activities. Mention may also be made of nitrophenol and nitroaniline substrates and derivatives, making it possible to detect osidase and esterase activities in the case of substrates based on nitrophenol, and peptidase activities in the case of substrates based on nitroaniline.
  • substrates based on naphthol and naphthylamine and their derivatives which make it possible to detect the osidase and esterase activities via naphthol, and the peptidase activities via naphthylamine.
  • This substrate may in particular, but in a nonlimiting manner, allow the detection of an enzymatic activity such as the activity of an osidase, peptidase, esterase, etc.
  • the enzyme substrate may also be a natural substrate, the product of which hydrolysis is detected directly or indirectly.
  • Tryptophan for detecting tryptophanase or desaminase activity
  • a cyclic amino acid for detecting a desaminase activity
  • Phosphatidyl Inositol for detecting phospholipase activity
  • the substrate is preferably selected from indoxyl-based substrates (3-Indoxyl, 5-Bromo-3-indoxyl, 5-Iodo-3-indoxyl, 4-Chloro-3-indoxyl, 5-Bromo- 4-chloro-3-indoxyl, 6-bromo-3-indoxyl, 6-fluoro-3-indoxyl, 5-bromo-4-chloro-N-methyl-3-indoxyl, N-methyl-3-indoxyl, .); based on umbelliferone (4-Methylumbelliferone, Cyclohexenoesculetin, ...); Alizarin based; p-Naphtolbenzene; Nitrophenol-based (ortho-Nitrophenol, para-Nitrophenol, ...); at Aminophenol base (para-Aminophenol, Dichloro-aminophenol, ...); Hydroxyquinoline; Cathecol (Cathecol, Dihydroxyflavone, Hydramino
  • the substrates used for the detection of a beta-glucuronidase activity may in particular be 4-methylumbelliferyl-beta-glucuronide, 5-Bromo-4-chloro
  • the substrates used for the detection of a beta-galactosidase activity may in particular be 4-methylumbelliferyl-beta-galactoside, 5-Bromo-4-chloro
  • the substrates used for the detection of a beta-glucosidase activity may especially be 4-methylumbelliferyl-beta-Glucoside, 5-Bromo-4-chloro-3-indolyl-beta-glucoside, 5-Bromo-6-chloro 3-indolyl-beta-glucoside, 6-chloro-3-indolyl-beta-glucoside, Alizarin-beta-glucoside, Cyclohexenosculetin-beta-Glucoside,
  • alpha-galactosidase substrate mention may be made of 4-methylumbelliferyl-alpha-galactoside, 5-Bromo-4-chloro-3-indolyl-alpha-galactoside and 5-Bromo-6-chloro-galactoside.
  • 3-indolyl-alpha-galactoside 6-chloro-3-indolyl-alpha-galactoside, Alizarin-alpha-galactoside, Nitrophenyl-alpha-galactoside or their salts.
  • enzyme A or C expressed by the majority of E. coli, is meant an enzyme which is expressed by more than 80% of E. coli under given conditions.
  • Lactose tryptophanase
  • enzyme B not expressed by the majority of E. coli, is meant an enzyme which is expressed by less than 20% of E. coli under given conditions.
  • beta-glucosidase N-acetyl hexosaminidase
  • esterase sulfatase
  • beta-cellobiosidase alpha-glucosidase
  • deaminase oxidase
  • pigment synthesis beta-Alanine aminopeptidase, elastase.
  • indole test is meant a test to detect the production of indole by microorganisms.
  • the indole produced in a reaction medium is detected using a reagent, such as Kovacs reagent, dimethylamino cinnamaldehyde.
  • inducer is meant a compound inducing an increase in the expression of the targeted metabolic activity, any experimental condition being equal, the metabolic activity is greater when the inducer is at an appropriate concentration than when it is absent or at an inappropriate concentration.
  • a glucuronide preferably chosen from Glucuronate, methyl-beta-glucuronide.
  • beta-galactosidase a beta-galactoside, preferentially chosen from Lactose, Isopropyl-beta-thio-galactoside
  • beta-glucosidase a carbohydrate consisting of a carbohydrate bound in the ⁇ position to glucose or carbohydrate with a ⁇ -glucoside subunit, in particular cellobiose, cellulose, starch, cellotriosis, trehalose. Mention may also be made of Methyl- ⁇ -glucoside, Isopropyl- ⁇ -thio-glucoside, Indoxyl- ⁇ -glucoside or Methyl- ⁇ -thio-glucoside.
  • alpha-galactosidase an alpha-galactoside, preferentially chosen from Melibiose, methyl-alpha-galactoside.
  • the invention relates to a method for detecting and / or identifying Escherichia coli (E. coli) in a biological sample according to which a) the biological sample capable of containing E. coli is inoculated on a medium.
  • detection method comprising tryptophan and a substrate of an enzyme A, expressed by the majority of E. coli to obtain colonies of bacteria b) colonies expressing the activity of the enzyme A are detected, and are identified as being E. coli c) colonies not expressing the activity of the enzyme A were detected, an indole test was performed, and colonies with a positive indole test were identified as E. coli.
  • the seeding of the microorganisms can be carried out by all the seeding techniques known to those skilled in the art.
  • An incubation step can be carried out at a temperature for which the enzymatic activity that one wishes to detect is optimal, that the person skilled in the art can easily choose according to the enzymatic activity to be detected.
  • the detection / identification can be carried out by visual examination, colorimetry or fluorimetry.
  • the enzyme A is selected from beta glucuronidase, alpha-galactosidase, beta-ribosidase, phosphatase, L-alanine aminopeptidase, L-Leucine aminopeptidase and beta-galactosidase.
  • the enzyme A is beta-glucuronidase.
  • the substrate of a beta-glucuronidase activity is chosen from 4-methylumbelliferyl-beta-glucuronide, 5-Bromo-4-chloro-3-indolyl-beta-glucuronide and 5-Bromo-6-chloro-3.
  • the enzyme A is beta-galactosidase.
  • the substrate of a beta-galactosidase activity is chosen from 4-methylumbelliferyl-beta-galactoside, 5-Bromo-4-chloro-3-indolyl- beta-galactoside, 5-Bromo-6-chloro-3-indolyl-beta-galactoside, 6-chloro-3-indolyl-beta-galactoside, Alizarin-beta-galactoside, Cyclohexenoesculetin-beta-galactoside or their salts, at a concentration preferably between 10 and 1000 mg / l, preferably between 20 and 500 mg / l.
  • the substrate of said enzyme A is at a concentration of between
  • the tryptophan concentration is equal to or greater than 0.02 g / l, preferably equal to or greater than 0.4 g / l.
  • the detection medium further comprises a substrate of an enzyme B, not expressed by the majority of E. coli.
  • the enzyme B is chosen from beta-glucosidase, N-acetyl hexosaminidase, esterase, sulfatase, beta-cellobiosidase, alpha-glucosidase, deaminase, oxidase, pigment synthesis, beta- Alanine aminopeptidase, elastase.
  • the enzyme B is beta-glucosidase.
  • the substrate of a beta-glucosidase activity is chosen from A-
  • Methylumbelliferyl-beta-Glucoside 5-Bromo-4-chloro-3-indolyl-beta-glucoside, 5-
  • the substrate of said enzyme B is at a concentration of between
  • the detection medium further comprises a substrate of an enzyme C, expressed by the majority of E. al.
  • the enzyme C is identical to the enzyme A, in which case the substrate must be different.
  • beta-galactosidase may be mentioned as enzyme A and C.
  • the medium comprises, for example, as substrate for the enzyme A, 4-Methylumbelliferyl-beta-glucuronide and as substrate for the enzyme C, 5-Bromo-6-chloro-3-indolyl-beta-glucuronide.
  • enzyme C is different from the enzyme A, beta-galactosidase, for example, may be mentioned as enzyme A, in combination with, as enzyme C, alpha-galactosidase.
  • Beta-galactosidase in combination with, as enzyme C, beta-glucuronidase, may also be mentioned as enzyme.
  • the enzyme C is selected from beta-glucuronidase, alpha-galactosidase, beta-ribosidase, phosphatase, L-alanine aminopeptidase, L-Leucine aminopeptidase, beta-galactosidase.
  • the enzyme C is beta-glucuronidase.
  • the substrate of a beta-glucuronidase activity is chosen from 4-methylumbelliferyl-beta-glucuronide, 5-Bromo-4-chloro-3-indolyl-beta-glucuronide, 5-Bromo-6-chloro-3 -indolyl-beta-glucuronide, 6-chloro-3-indolyl-beta-glucuronide, Alizarin-beta-glucuronide, Cyclohexenoesculetin-beta-glucuronide or their salts, at concentrations preferably comprised between 10 and 1000 mg / l.
  • the enzyme C is alpha-galactosidase.
  • the substrate of an alpha-galactosidase activity is chosen from 4-methylumbelliferyl-alpha-galactoside, 5-Bromo-4-chloro-3-indolyl-alpha-galactoside and 5-Bromo-6-chloro-3.
  • the substrate of said enzyme C is at a concentration of between 10 and 1000 mg / l, preferably between 20 and 500 mg / l.
  • the enzyme A is beta-galactosidase
  • enzyme B is beta-glucosidase
  • enzyme C is alpha-galactosidase.
  • the substrate of the enzyme A is preferably 5-Bromo-4-chloro-3-indolyl-beta-galactoside, 5-Bromo-6-chloro-3-indolyl-beta-galactoside, 6-chloro-3 -indolyl-beta-galactoside, Alizarin-beta-galactoside, at a concentration of between 10 and 1000 mg / l
  • the substrate of the enzyme B is preferably 5-Bromo-4-chloro-3-indolyl-beta-glucoside, 5-Bromo-6-chloro-3-indolyl-beta-glucoside, 6-Chloro-3 indolyl-beta-glucoside, Alizarin-beta-glucoside, at a concentration of between 10 and 1000 mg / l,
  • the substrate of the enzyme C is preferably 5-Bromo-4-chloro-3-indolyl-alpha-galactoside, 5-Bromo-6-chloro-3-indolyl-alpha-galactoside, 6-chloro-3- indolyl-alpha-galactoside, Alizarin-alpha-galactoside at a concentration of between 10 and 1000 mg / l,
  • the enzyme A is beta-galactosidase
  • enzyme B is beta-glucosidase
  • enzyme C is beta-glucuronidase
  • the substrate of the enzyme A is preferably 5-Bromo-4-chloro-3-indolyl-beta-galactoside, 5-Bromo-6-chloro-3-indolyl-beta-galactoside, 6-chloro-3 -indolyl-beta-galactoside, Alizarin-beta-galactoside, at a concentration of between 10 and 1000 mg / l,
  • the substrate of the enzyme B is preferably 5-Bromo-4-chloro-3-indolyl-beta-glucoside, 5-Bromo-6-chloro-3-indolyl-beta-glucoside, 6-Chloro-3 indolyl-beta-glucoside, Alizarin-beta-glucoside, at a concentration of between 10 and 1000 mg / l,
  • the substrate of the enzyme C is preferably 5-Bromo-4-chloro-3-indolyl-beta-glucuronide, 5-Bromo-6-chloro-3-indolyl-beta-glucuronide, 6-chloro-3 -indolyl-beta-glucuronide, Alizarin-beta-glucuronide, at a concentration of between 10 and 1000 mg / l
  • the detection medium further comprises an inducer of the enzyme A, an inducer of the enzyme B and / or an inducer of the enzyme C.
  • the inducer of the enzyme A, B or C is at a concentration of between 100 ng / l and 10 g / l, preferably between 10 mg / l and 3 g / l.
  • the inducer of said enzyme A or C is preferably a glucuronide, preferably chosen from Glucuronate,
  • Methyl beta- glucuronide Methyl beta- glucuronide
  • the inducer of said enzyme A or C is preferably a beta-galactoside, preferably selected from Lactose, Isopropyl-beta-thio-galactoside.
  • the inducer of the enzyme B is preferably a beta-glucoside, preferentially chosen from methyl-beta-glucose, cellobiose, cellotriose, trehalose, cellulose, starch.
  • the inducer of the enzyme B is Cellobiose, at a concentration preferably between 10 mg / l to 10 g / l
  • the inducer of the enzyme C is preferably Melibiose, methyl-alpha-galactoside.
  • the invention also relates to a detection medium comprising tryptophan, a substrate of a beta-galactosidase enzyme, a substrate of a beta-glucosidase enzyme, and cellobiose.
  • the concentration of tryptophan is equal to or greater than 0.02 g / l, preferably equal to or greater than 0.4 g / l.
  • the substrate of a beta-glucosidase activity is chosen from 4-methylumbelliferyl-beta-glucoside, 5-Bromo-4-chloro-3-indolyl-beta-glucoside, and 5-bromo-6-chloro-3.
  • the substrate of a beta-galactosidase activity is chosen from 4-methylumbelliferyl-beta-galactoside, 5-Bromo-4-chloro-3-indolyl-beta-galactoside, and 5-Bromo-6-chloro-3 -indolyl-beta-galactoside, 6-chloro-3-indolyl-beta-galactoside, Alizarin-beta-galactoside, Cyclohexenoesculetin-beta-galactoside or their salts, a concentration preferably between 10 and 1000 mg / l, preferably between 20 and 500 mg / l.
  • the cellobiose is at a concentration of between 10 mg / l and 10 g / l.
  • the detection medium further comprises a substrate of an alpha-galactosidase enzyme.
  • alpha-galactosidase substrates examples include 4-methylumbelliferyl-alpha-galactoside, 5-Bromo-4-chloro-3-indolyl-alpha-galactoside and 5-Bromo-6-chloro-3-indolyl.
  • the invention also relates to the use of a medium as defined above for detecting E. coli.
  • Example 1 Contribution of the Indole test to colorless colonies for the detection of Escherichia coli
  • Trypcase Soya Agar (bioMérieux) are added Tryptophan at 0,9g / l, 6-Chloro-3-indolyl- ⁇ -glucuronide at 0.15g / l of 5-Bromo-6-chloro-3-indolyl- ⁇ -galactoside at 0.05 g / l and 5-Bromo-4-chloro-3-indolyl- ⁇ -glucoside at 0.1 g / l.
  • This medium is or is not added with Cellobiose at 0.5 g / l. These two media are distributed at a rate of 20 ml per petri dish.
  • Microorganisms frequently isolated from urinary samples and from the plaintiff's collection are inoculated on these media by semi-quantitative isolation of 10 ⁇ l of a 0.5 McFarland suspension diluted to 20 e .
  • the dishes are incubated at 37 ° C. for 24 hours, then the colonies formed are examined visually. The coloration of these colonies is noted.
  • An Indole test is performed on colorless colonies using James's reagent (bioMérieux). The results are shown in Table 2 below:
  • Table 2 Contribution of the Indole test to a medium combining 6-chloro-3-indolyl- ⁇ -glucuronide, 5-Bromo-6-chloro-3-indolyl- ⁇ -galactoside and 5-Bromo-4-chloro-3-indolyl - ⁇ -glucoside supplemented or not with Cellobiose on the identification of E. coli

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP08762042A 2007-02-08 2008-02-07 Milieu de détection et/ou d'identification de bactéries Withdrawn EP2111462A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0753150A FR2912425B1 (fr) 2007-02-08 2007-02-08 Milieu de detection et/ou d'identification de bacteries
PCT/FR2008/050184 WO2008104680A2 (fr) 2007-02-08 2008-02-07 Milieu de détection et/ou d'identification de bactéries

Publications (1)

Publication Number Publication Date
EP2111462A2 true EP2111462A2 (fr) 2009-10-28

Family

ID=38458115

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08762042A Withdrawn EP2111462A2 (fr) 2007-02-08 2008-02-07 Milieu de détection et/ou d'identification de bactéries

Country Status (7)

Country Link
US (1) US8334112B2 (ja)
EP (1) EP2111462A2 (ja)
JP (1) JP2010517551A (ja)
CN (1) CN101631875B (ja)
AU (1) AU2008220704B2 (ja)
FR (1) FR2912425B1 (ja)
WO (1) WO2008104680A2 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912423B1 (fr) * 2007-02-08 2009-03-20 Biomerieux Sa Milieu de detection et/ou d'identification de bacteries
JP2011244761A (ja) * 2010-05-28 2011-12-08 Nissui Pharm Co Ltd エンテロバクターサカザキ菌検出用培地
FR3000501B1 (fr) 2012-12-28 2015-08-14 Biomerieux Sa Milieu de detection de micro-organismes comprenant au moins un alkyl(thio)glycoside
FR3004195B1 (fr) 2013-04-03 2017-10-06 Biomerieux Sa Utilisation d'au moins un substrat de phosphatase chromogene et/ou fluorogene pour la detection et/ou le denombrement d'enterobacteries dans un echantillon biologique.
JP2016523566A (ja) 2013-07-18 2016-08-12 ネステク ソシエテ アノニム 高トリグリセリド血症用マーカーとしての大腸菌
GB201319768D0 (en) 2013-11-08 2013-12-25 Glycosynth Ltd Naphthalene derived chromogenic enzyme substrates
TR201912725A2 (tr) * 2019-08-23 2021-03-22 Pamukkale Ueniversitesi Bi̇r hi̇jyen tespi̇t ci̇hazi

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027536C (en) * 1990-05-14 1993-02-16 George Chang Method for determination of e.coli in water
US6146840A (en) * 1994-04-29 2000-11-14 The Regents Of The University Of California Simultaneous enumeration of E. coli and total coliforms
US5888760A (en) * 1997-04-10 1999-03-30 Dade Microscan Inc. Universal test systems and methods of use thereof for identifying multiple families of microorganisms
FR2881755B1 (fr) * 2005-02-10 2012-11-30 Biomerieux Sa Milieux pour la detection specifique de micro-organismes resistants
FR2882370B1 (fr) * 2005-02-22 2010-12-03 Alain Rambach Detection d'une souche de microorganismes dans un echantillon liquide

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008104680A3 *

Also Published As

Publication number Publication date
FR2912425A1 (fr) 2008-08-15
AU2008220704A1 (en) 2008-09-04
CN101631875A (zh) 2010-01-20
AU2008220704B2 (en) 2013-10-10
CN101631875B (zh) 2013-05-15
WO2008104680A3 (fr) 2008-11-06
JP2010517551A (ja) 2010-05-27
WO2008104680A2 (fr) 2008-09-04
US20100062467A1 (en) 2010-03-11
US8334112B2 (en) 2012-12-18
FR2912425B1 (fr) 2012-08-31

Similar Documents

Publication Publication Date Title
WO2008104681A2 (fr) Milieu de détection et/ou d'identification de bactéries
EP2111460B1 (fr) Milieu de détection et/ou d'identification de bactéries
EP2111462A2 (fr) Milieu de détection et/ou d'identification de bactéries
JP2008530993A (ja) 液体試料中の微生物株の検出
EP2235202A2 (fr) Procédé de détection et/ou d'identification de clostridium difficile
EP2877591B1 (fr) Procede de detection de bacteries productrices de carbapenemases de type oxa-048
EP3094738B1 (fr) Utilisation d'au moins un substrat de carboxylestérase et/ou de triacylglycérol-lipase pour la détection des bactéries du groupe bacillus cereus
EP2981619B1 (fr) Utilisation d'au moins un substrat de phosphatase chromogène et/ou fluorogène pour la détection et/ou le dénombrement d'entérobactéries dans un échantillon
EP1888767A2 (fr) Milieu reactionnel pour les bacteries vibrio
FR3000501A1 (fr) Milieu de detection de micro-organismes comprenant au moins un alkyl(thio)glycoside
EP2205976A2 (fr) Test biochimique pour confirmer la presence de l. monocytogenes
WO2013107994A1 (fr) Detection in vitro de microorganismes presentant une activite azoreductase
EP2670858B1 (fr) Milieu de culture de microorganismes comprenant l'acide para-aminobenzoique comme agent selectif

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090717

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20091209

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MONGET, DANIEL

Inventor name: PEYRET, MICHEL

Inventor name: ORENGA, SYLVAIN

Inventor name: PERRY, JOHN

Inventor name: ROGER-DALBERT, CELINE

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150519

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20150930